Table III.
Summary of univariate and multivariate Cox regression analyses of overall survival duration in patients with bladder cancer.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Characteristics | HR (95% CI) | P-valuea | HR (95% CI) | P-valuea |
| Age (≥65/<65 years) | 0.859 (0.400–1.842) | 0.696 | ||
| Gender (female/male) | 0.766 (0.362–1.620) | 0.484 | ||
| Histological grade (GI/GII–III) | 1.359 (0.596–3.103) | 0.466 | ||
| T stage (T2-T4/Ta-T1) | 2.351 (1.081–5.113) | 0.031 | 2.338 (1.062–5.146) | 0.035 |
| Distant metastasis (present/absent) | 3.015 (1.216–7.478) | 0.017 | 3.402 (1.341–8.632) | 0.010 |
| Multiplicity (multiple/single) | 1.568 (0.722–3.405) | 0.225 | ||
| TMSB10 (high/low) | 0.402 (0.171–0.946) | 0.037 | 0.418 (0.177–0.988) | 0.047 |
a
Values in bold are considered statistically significant. TMSB10, thymosin β10; HR, hazard ratio; CI, confidence interval.